Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

CGM Dynamic Index for Predicting Prediabetes in Cystic Fibrosis

NCT: NCT06642610 · COMPLETED

NCT IDNCT06642610
StatusCOMPLETED
Start Date2025-06-15
Completion2026-06-30
SponsorIndiana University (OTHER)
First posted
Last updated

Brief Summary

The primary objective of this pilot study is to develop a CGM-based model to predict the progression from prediabetes to diabetes in individuals with cystic fibrosis.

Frequently Asked Questions

What is CGM Dynamic Index for Predicting Prediabetes in Cystic Fibrosis?

CGM Dynamic Index for Predicting Prediabetes in Cystic Fibrosis is a clinical trial registered under NCT06642610. Current status: COMPLETED.

What is the status of NCT06642610?

The current status of NCT06642610 (CGM Dynamic Index for Predicting Prediabetes in Cystic Fibrosis) is: COMPLETED.

When did CGM Dynamic Index for Predicting Prediabetes in Cystic Fibrosis start?

CGM Dynamic Index for Predicting Prediabetes in Cystic Fibrosis started on 2025-06-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.